Inverness Graham Investments
Inverness Graham Investments is a Wayne, Pennsylvania-based private equity firm founded in 2003 that acquires founder-owned healthcare, software, advanced manufacturing, and sustainability businesses in the North American lower middle market, managing over $1.8 billion in AUM.
- Company typePrivate
- Founded2003
- HeadquartersNewtown Square, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Inverness Graham Investments does
Inverness Graham Investments is an operationally focused private investment firm founded in 2003 by Kenneth A. Graham, building on the 60-year operating heritage of the Graham Group. The firm is headquartered in Wayne, Pennsylvania, and invests in founder-owned and founder-led businesses in the North American lower middle market, executing majority control buyouts typically of $40M-$80M equity in companies with $10M-$100M revenue and up to $20M EBITDA under its Flagship strategy, and $20M-$50M equity checks under its Green Light sustainability-focused strategy. Across more than two decades the firm has completed over 110 transactions, managing over $1.8 billion in assets under management as of May 2026, with Fund V closing at $400 million.
The firm employs a proprietary Strategic Platform Build approach, partnering with founder-management teams and contributing business-building expertise, operational resources from its Value Creation Group, and strategic add-on acquisitions to accelerate growth. Deal sourcing is supported by an Industry Executive Partner network of 40+ current and former C-suite executives who develop investment themes and source targets proactively. The firm generates revenue through management fees on committed fund capital and carried interest on portfolio exits, with its limited partner base comprising institutional investors including endowments, foundations, pension funds, and family offices. The portfolio spans 20+ active companies across healthcare (Innovia Medical, VitalPath, Biolyst Scientific), tech-enabled services and software (Syntrio, Cognito Forms, Alliant, BenefitHub, GPS Trackit, Corsica Technologies), advanced manufacturing (EiKO Global, KICTeam, Smartflow), and sustainability (Custom Agronomics, My Yield).
Inverness Graham Investments firmographics
Firmographics- Name
- Inverness Graham Investments
- Legal name
- Inverness Graham
- Website
- https://invernessgraham.com
- Company type
- Private
- Founded year
- 2003
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Inverness Graham Investments is a Wayne, Pennsylvania-based private equity firm founded in 2003 that acquires founder-owned healthcare, software, advanced manufacturing, and sustainability businesses in the North American lower middle market, managing over $1.8 billion in AUM.
- Ownership category
- akta.pro rank
Inverness Graham Investments industry classification
Industry- Product category
- Private Equity / Buyout Fund Management
- NAICS
- All Other Financial Investment Activities (52399), Other Financial Investment Activities (5239)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Multi-Sector / Generalist Growth Equity (FSANACAO)
- akta.pro secondary industry
- Corporate Strategy Advisory (BPAHADAA)
Keywords
Where Inverness Graham Investments is headquartered
LocationHeadquarters
- HQ city
- Newtown Square
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Inverness Graham Investments business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Fund Management Fees and Carried Interest: Inverness Graham generates revenue through management fees charged on assets under management across its Flagship and Green Light fund strategies, as well as carried interest (performance fees) generated upon successful exits of portfolio investments. The firm raised over $825 million in capital commitments over the past three years across all vehicles and strategies, culminating in Fund V closing at $400 million, bringing total AUM to more than $1.8 billion.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
Inverness Graham Investments product offering
Product offeringCore offering
Inverness Graham Investments is an operationally focused private equity firm that acquires controlling stakes in founder-owned and founder-led businesses in the North American lower middle market. The firm executes two fund strategies: a Flagship strategy targeting healthcare, tech-enabled services/software, and advanced manufacturing companies with $10M–$100M revenue and up to $20M EBITDA (equity checks of $40M–$80M), and a Green Light sustainability-focused strategy targeting companies with up to $10M EBITDA (equity checks of $20M–$50M). Across both strategies, the firm provides majority control capital, operational support via its Value Creation Group and Industry Executive Partners, and drives growth through organic expansion and strategic add-on acquisitions.
Product overview
Inverness Graham Investments is an operationally focused private equity firm, not a technology product company. The firm executes two distinct investment strategies: the Flagship Strategy targeting high-growth businesses in Healthcare, Tech-Enabled Services/Software, and Advanced Manufacturing; and the Green Light Strategy targeting sustainability-focused tech-enabled businesses. The firm employs a Strategic Platform Build approach to build enduring value through operational enhancements and transformative M&A. The firm's portfolio of 20+ active investments spans diverse sectors including professional education technology (Axcel Learning), healthcare manufacturing (Innovia Medical, VitalPath, Biolyst Scientific), enterprise software (Syntrio, Cognito Forms, Spirion), marketing technology (Alliant), fleet management (GPS Trackit), agriculture technology (My Yield, Custom Agronomics), and various industrial and service businesses. The firm manages over $1.8 billion in assets under management across its diversified lower middle market platform.
Differentiator
Problem solved
Functional benefit
Brands
- Strategic Platform Build: The firm's proprietary approach to building businesses of enduring value through operational enhancements and transformative M&A.
- Value Creation Group
- Industry Executive Partner Program
Products and services
- Inverness Graham Flagship Strategy Private equity investment strategy targeting high-growth businesses in Healthcare, Tech-Enabled Services/Software, and Advanced Manufacturing with majority control investments of $40M–$80M equity in companies with $10M–$100M revenue and up to $20M EBITDA.
- Inverness Graham Green Light Strategy Sustainability-focused private equity investment strategy targeting tech-enabled businesses where environmental sustainability drives growth acceleration, with equity investments of $20M–$50M in companies with up to $10M EBITDA across AgTech, energy transition, industrial transition, and built world transition themes.
- Strategic Platform Build Approach Proprietary value creation approach refined over two decades, supporting portfolio management teams to drive organic growth while scaling platforms strategically through add-on acquisitions, paired with operational resources from the Value Creation Group and Industry Executive Partners.
- Inverness Graham Investments V (Fund V) Fifth flagship buyout fund of Inverness Graham, closed at $400 million, with proceeds used to continue the strategy of partnering with founder-owned and founder-led businesses in Healthcare, Tech-Enabled Services and Software, and Advanced Manufacturing sectors.
Quantifiable outcome
- 110+ transactions completed across 21 years of operating history
- +3 more outcomes
Companies that use Inverness Graham Investments
Customer profileNamed customers16 records
Segments5 records
Ideal customer profiles3 records
Inverness Graham Investments technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability1 record
Inverness Graham Investments partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and add-on.
- Latham & Watkins LLPcoreLatham & Watkins LLP served as legal counsel for the Fund V closing. The firm provides legal advisory services for fund formation, regulatory compliance, and transaction documentation across Inverness Graham's investment activities.
- Grace Medicaladd-onInnovia Medical (an Inverness Graham portfolio company) acquired Grace Medical, a Memphis-based maker of single-use surgical implants and instruments for ENT (Ear, Nose, and Throat) procedures. The acquisition expanded Innovia's presence in the ENT surgical market and enhanced its product portfolio and manufacturing capabilities.
- Hurricane Medicaladd-onInnovia Medical (an Inverness Graham portfolio company) acquired Hurricane Medical, a Bradenton, Florida-based manufacturer of single-use ophthalmic surgical products. The acquisition expanded Innovia's presence in the ophthalmic surgical market and created synergy opportunities with new and existing customers.
- AnalyticsIQadd-onAlliant (an Inverness Graham portfolio company) acquired AnalyticsIQ, a predictive analytics and people-based marketing data company. The acquisition combined Alliant's proprietary transaction data with AnalyticsIQ's predictive modeling capabilities to create a differentiated data platform. Scarlett Shipp, formerly CEO of AnalyticsIQ, was appointed CEO of the combined business.
Scale indicators7 records
Recent moves7 records
Expansion highlights6 records
Inverness Graham Investments competitors and assessment
Company assessmentDirect peers
- Graham Partners: Family-affiliated operationally focused private equity firm investing in advanced manufacturing, industrial technology, and consumer-related businesses, with a similar middle-market buyout approach and Graham family heritage.
- Audax Group: One of the largest lower middle market PE platforms with a similar buy-and-build approach targeting founder-owned businesses with $10M-$100M revenue, making it a direct competitor in deal sourcing and platform construction.
- Shore Capital Partners: Lower middle market PE firm focused on healthcare, food and beverage, and business services, with a comparable thesis around founder-led businesses and Strategic Platform Build-style execution (and the original sponsor of Innovia Medical before Inverness Graham's acquisition).
- Genstar Capital: Lower middle market PE firm investing in technology, healthcare, financial services, and industrials, with a similar buyout orientation and multi-vertical platform approach.
- Frontenac Company: Lower middle market PE firm focused on founder-owned businesses with $10M-$100M revenue, closely comparable in target company profile and value creation orientation to Inverness Graham.
- Trinity Hunt Partners: Lower middle market growth-oriented PE firm investing in business services, healthcare, and consumer companies, with comparable deal size and operating partner engagement model.
- Brentwood Associates: Lower middle market PE firm focused on consumer, healthcare, and business services, with comparable founder-friendly positioning and platform-build approach.
Broad incumbents
- L Catterton: Large consumer-focused PE firm with diversified strategies including a growth fund that competes for platform deals in the lower middle market, overlapping with Inverness Graham's consumer/retail portfolio companies like Treat Planet.
- Avista Capital Partners: Healthcare-focused PE firm that competes with Inverness Graham in healthcare platforms, medical device manufacturing, and pharma services investments across the middle market.
- Linden Capital Partners: Healthcare-specialist PE firm operating in the lower middle market, directly comparable in healthcare verticals like medical devices and lab consumables.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Inverness Graham Investments social profiles
Digital presenceInverness Graham Investments financial estimates
Financial estimateRevenue estimate
Valuation estimate
Inverness Graham Investments leadership team
Management profileNumber of profiles
Profiles11 records
Inverness Graham Investments subsidiaries and ownership
Company hierarchySubsidiaries18 records
Inverness Graham Investments funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Inverness Graham Investments M&A and investment
M&A and investmentM&A15 records
Investments6 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Inverness Graham Investments
What does Inverness Graham Investments do?
Inverness Graham Investments is an operationally focused private equity firm that acquires controlling stakes in founder-owned and founder-led businesses in the North American lower middle market. The firm executes two fund strategies: a Flagship strategy targeting healthcare, tech-enabled services/software, and advanced manufacturing companies with $10M–$100M revenue and up to $20M EBITDA (equity checks of $40M–$80M), and a Green Light sustainability-focused strategy targeting companies with up to $10M EBITDA (equity checks of $20M–$50M). Across both strategies, the firm provides majority control capital, operational support via its Value Creation Group and Industry Executive Partners, and drives growth through organic expansion and strategic add-on acquisitions.
Is Inverness Graham Investments a public or private company?
Inverness Graham Investments is a private company. It is classified as management employee owned and is currently operating.
When was Inverness Graham Investments founded?
Inverness Graham Investments was founded in 2003. It employs 11 to 50 people.
Where is Inverness Graham Investments based?
Inverness Graham Investments is headquartered in Newtown Square, United States, in the North America region.
How does Inverness Graham Investments make money?
One revenue line is on record: fund Management Fees and Carried Interest.
Who are Inverness Graham Investments's main competitors?
Direct peers on record are Graham Partners, Audax Group, Shore Capital Partners, Genstar Capital, Frontenac Company, Trinity Hunt Partners and Brentwood Associates. Broad incumbents are L Catterton, Avista Capital Partners and Linden Capital Partners.
Does Inverness Graham Investments have an API?
No public API is recorded for Inverness Graham Investments.
What industry is Inverness Graham Investments in?
Inverness Graham Investments's product category is Private Equity / Buyout Fund Management. Its primary akta.pro industry code is FSANACAO, Multi-Sector / Generalist Growth Equity, with a secondary code of BPAHADAA, Corporate Strategy Advisory. Its NAICS code is 52399 and its SIC code is 6282.